The Dako Omnis test identifies mismatch repair deficiencies in colorectal cancer, aiding in treatment decisions and potentially improving patient outcomes. Hernexeos, a kinase inhibitor, offers a new ...
Lynozyfic received accelerated approval for relapsed multiple myeloma, showing a 70% response rate but with notable side effects, including cytokine release syndrome and neurologic toxicity. Zegfrovy ...
The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...
If you’ve been wondering, “When will the 2025 COVID vaccine be widely available?” you’re not alone. By this time last year, the 2024-25 COVID-19 vaccines had already been approved by the Food and Drug ...
WASHINGTON (AP) — The Food and Drug Administration on Thursday announced the first round of experimental drugs that will receive drastically expedited reviews at the agency, part of an effort to ...
For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration has approved Insmed's daily pill brensocatib, which will be sold under the brand name ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback